Batf3+ DCs and type I IFN are critical for the efficacy of neoadjuvant cancer immunotherapy
| Image |  |
|---|---|
| Description | scientific article published on 22 November 2018 |
| Author/s | |
| Publication date | November 22, 2018 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |